 |
 |
|
|
RESÚMENES JUNIO 2007 |
Basic Neuroscience & Pharmacology
(Haga un click en la información del journal para acceder al resúmen)
Short-term
antidepressant treatment and facial processing.
Functional magnetic resonance imaging study
RAY NORBURY, CLARE E. MACKAY, PHILIP J. COWEN, GUY M. GOODWIN, CATHERINE
J. HARMER
The British Journal of Psychiatry (2007) 190:
531-532
Drug
metabolite profiling and elucidation of drug-induced hepatotoxicity
Wei Tang
Expert Opinion on Drug Metabolism & Toxicology. June 2007, Vol. 3, No. 3, Pages 407-420
Serum levels of
brain-derived neurotrophic factor in patients with
schizophrenia and bipolar disorder
Clarissa Severino Gama, Ana Cristina Andreazza, Maurício Kunz, Michael
Berk, Paulo Silva Belmonte-de-Abreu and Flavio Kapczinski
Neuroscience
Letters.
Volume 420, Issue 1, 8 June 2007, Pages 45-48
Quetiapine
reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in
rat caudate putamen following long-term haloperidol
treatment
Yanbo Zhang,
Haiyun Xu, Jue He, Bin Yan, Wengao Jiang, Xiaokun Li, Xin-Min Li
Neuroscience
Letters.
Volume 420, Issue 1, 8 June 2007, Pages 66-71
Myelin staining of
deep white matter in the dorsolateral prefrontal
cortex in schizophrenia, bipolar disorder, and unipolar
major depression
William T. Regenold, Pornima Phatak, Christopher M. Marano,
Lorie Gearhart, Claudia H. Viens and K. Calvin Hisley
Psychiatry
Research.
Volume 151, Issue 3, 30 June 2007, Pages 179-188
Neopterin
levels and dexamethasone suppression test in
obsessive–compulsive disorder
Murat Kuloğlu, Murad Atmaca, Süleyman Önal, Ömer Geçici, Vedat Bulut
and Ertan Tezcan
Psychiatry
Research.
Volume 151, Issue 3, 30 June 2007, Pages 265-270
Chlorpromazine
exacerbates hepatic insulin sensitivity via attenuating insulin and leptin signaling pathway, while exercise partially reverses
the adverse effects
Life Sciences. Volume 80, Issue 26, 6
June 2007, Pages 2428-2435
Anterior cingulate volumes in schizophrenia: A systematic review and
a meta-analysis of MRI studies
M. Baiano, A. David, A. Versace, R. Churchill, M. Balestrieri and P. Brambilla
Schizophrenia
Research.
Volume 93, Issues 1-3, July 2007, Pages 1-12
Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger
onset age: A single-voxel 1H spectroscopy
study
Jeffrey A.
Stanley, Madhuri Vemulapalli,
Jeffrey Nutche, Debra M. Montrose, John A. Sweeney,
Jay W. Pettegrew, Frank P. MacMaster
and Matcheri S. Keshavan
Schizophrenia
Research.
Volume 93, Issues 1-3, July 2007, Pages 23-32
Abnormalities of cingulate gyrus neuroanatomy in schizophrenia
Lei Wang, Malini Hosakere, Joshua C.L. Trein, Alex Miller, J. Tilak Ratnanather, Deanna M. Barch,
Paul A. Thompson, Anqi Qiu,
Mokhtar H. Gado, Michael I.
Miller and John G. Csernansky
Schizophrenia
Research.
Volume 93, Issues 1-3, July 2007, Pages 66-78
Prefrontal–thalamic–cerebellar gray matter networks and executive functioning
in schizophrenia
Nicolas Rüsch, Ilaria Spoletini,
Marko Wilke, Pietro Bria, Margherita Di Paola, Fulvia Di Iulio, Giovanni Martinotti, Carlo Caltagirone and
Gianfranco Spalletta
Schizophrenia
Research.
Volume 93, Issues 1-3, July 2007, Pages 79-89
Orexin
and psychiatric symptoms in suicide attempters
Journal of Affective
Disorders. Volume 100, Issues 1-3, June 2007, Pages 259-263
Genetics of anxiety
disorders
Psychiatry. Volume 6, Issue 6, June
2007, Pages 258-262
TEXTO GRATUITO
Association Between
Treatment-Emergent Suicidal Ideation With Citalopram
and Polymorphisms Near Cyclic Adenosine Monophosphate
Response Element Binding Protein in the STAR*D Study
Roy H. Perlis, Shaun Purcell, Maurizio Fava, Jesen Fagerness,
A. John Rush, Madhukar H. Trivedi,
Jordan W. Smoller
Arch Gen Psychiatry. 2007;64:689-697
Reduced cerebral
glucose metabolism in patients at risk for Alzheimer's disease
Aoife Hunt,
Peter Schönknecht, Marcus Henze,
Ulrich Seidl, Uwe Haberkorn and Johannes Schröder
Psychiatry Research: Neuroimaging. Volume 155, Issue 2, 15 July 2007, Pages
147-154
When
brains expand: mind and the evolution of cortex
Matthew T. K. Kirkcaldie, Peter D. Kitchener
Acta Neuropsychiatrica 2007; 19
(3), 139–148
Glutamate and
monoamine transporters: new visions of form and function
Gonzalo E Torres and Susan
G Amara
Current Opinion in
Neurobiology. Volume 17, Issue 3, June 2007, Pages 304-312
Prefrontal cortical
functional abnormality in major depressive disorder: A stereotactic
meta-analysis
J. Douglas Steele,
James Currie, Stephen M. Lawrie and Ian Reid
Journal of Affective
Disorders. Volume 101, Issues 1-3, August 2007, Pages 1-11
Improvement in mood
and ideation associated with increase in right caudate volume
Monica N. Starkman, Bruno Giordani, Stephen
S. Gebarski and David E. Schteingart
Journal of Affective
Disorders. Volume 101, Issues 1-3, August 2007, Pages 139-147
Decreased plasma
BDNF level in depressive patients
Bun-Hee Lee, Hyun Kim,
Journal of Affective
Disorders. Volume 101, Issues 1-3, August 2007, Pages 239-244
Changes in the
Hypothalamic-Pituitary-Adrenal Axis and Leptin Levels
during Antidepressant Treatment
Hubertus Himmerich, Petra Zimmermann, Marcus Ising,
Stefan Kloiber, Susanne Lucae,
Heike E. Künzel, Elisabeth B. Binder, Florian Holsboer, Manfred Uhr
Neuropsychobiology 2007;55:28-35
Olanzapine Increases Grey and White Matter
Volumes in the Caudate Nucleus of Patients with Schizophrenia
Gaku Okugawa,
Kenji Nobuhara, Katsunori Takase, Yukiko Saito, Masafumi
Yoshimura, Toshihiko Kinoshita
Neuropsychobiology 2007;55:43-46
Informative phenotypes for genetic studies
of psychiatric disorders
Peter Szatmari , Michel Maziade,
Lonnie Zwaigenbaum, Chantal Mérette,
Marc-Andre Roy, Ridha Joober,
Roberta Palmour
Meta-analysis of COMT val158met in panic
disorder: Ethnic heterogeneity and gender specificity
Katharina Domschke , Juergen
Deckert, Michael C. O'Donovan, Stephen J. Glatt
Associations of a
Regulatory Polymorphism of Monoamine Oxidase-A Gene
Promoter (MAOA-uVNTR) With Symptoms of Depression and
Sleep Quality
Beverly H. Brummett, Andrew D. Krystal, Ilene
C. Siegler, Cynthia Kuhn, Richard S. Surwit, Stephan Züchner, Allison
Ashley-Koch, John C. Barefoot, and Redford B. Williams
Psychosomatic Medicine
69:396-401 (2007)
Interaction between serotonin transporter
gene, catechol-O-methyltransferase
gene and stressful life events in mood disorders
Laura Mandelli, Alessandro Serretti,
Elena Marino, Adele Pirovano,
Raffaella Calati
and Cristina Colombo
The
International Journal of Neuropsychopharmacology
(2007), 10: 437-447
The effects of acute tryptophan
depletion and serotonin transporter polymorphism on emotional processing in
memory and attention
Jonathan P. Roiser,
Ulrich Müller,
Luke Clark and Barbara J. Sahakian
The
International Journal of Neuropsychopharmacology
(2007), 10: 449-461
A fMRI
investigation of startle gating deficits in schizophrenia patients treated with
typical or atypical antipsychotics
Veena Kumari,
Elena Antonova,
Mark A. Geyer, Dominic ffytche,
Steven C. R. Williams and Tonmoy Sharma
The
International Journal of Neuropsychopharmacology
(2007), 10: 463-477
Oligodendrocyte pathophysiology:
a new view of schizophrenia
Devorah Segal, Jessica R. Koschnick, Linda H. A. Slegers
and Patrick R. Hof
The
International Journal of Neuropsychopharmacology
(2007), 10: 503-511
The role of oligodendrocyte
pathology in schizophrenia
Natalya A. Uranova,
Victor M. Vostrikov,
Olga V. Vikhreva,
Ivetta S. Zimina,
Natalya S. Kolomeets
and Diana D. Orlovskaya
The
International Journal of Neuropsychopharmacology
(2007), 10: 537-545
Oligodendroglial
abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or
molecular phenocopies?
Boris P. Sokolov
The
International Journal of Neuropsychopharmacology
(2007), 10: 547-555
Further evidence for altered myelin
biosynthesis and glutamatergic dysfunction in
schizophrenia
Dmitri Tkachev,
Michael L. Mimmack,
Stephen J. Huffaker,
Margaret Ryan and Sabine Bahn
The
International Journal of Neuropsychopharmacology
(2007), 10: 557-563
Variations in oligodendrocyte-related
gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia
Vahram Haroutunian,
Pavel Katsel,
Stella Dracheva,
Daniel G. Stewart and Kenneth L. Davis
The
International Journal of Neuropsychopharmacology
(2007), 10: 565-573
Intracellular amyloid-B in Alzheimer's disease
Frank M. LaFerla, Kim N. Green & Salvatore Oddo
Nature
Reviews Neuroscience 8,
499-509 (July 2007)
TEXTO
GRATUITO (luego de registro)
Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at
dopamine D2 receptors disrupt basal PPI of the startle reflex in rats
Agnès L. Auclair, Alexandra Galinier, Joël Besnard,
Adrian Newman-Tancredi and Ronan Depoortère
Psychopharmacology. Volume 193, Number 1 / July, 2007: 45-54
From prediction
error to psychosis: ketamine as a pharmacological model
of delusions
P.R. Corlett,
G.D. Honey, P.C. Fletcher
Journal of Psychopharmacology, Vol. 21, No. 3, 238-252
(2007)
Is Autoimmune Thyroiditis Part of the Genetic Vulnerability (or an Endophenotype) for Bipolar Disorder?
Ronald Vonk, Astrid C. van der Schot, René S. Kahn, Willem A. Nolen and
Hemmo A. Drexhage
Biological
Psychiatry. Volume 62, Issue 2, 15 July 2007, Pages 135-140
Affective Neural
Circuitry During Facial Emotion Processing in
Pediatric Bipolar Disorder
Mani N. Pavuluri, Megan Marlow O‘Connor, Erin Harral
and John A. Sweeney
Biological
Psychiatry. Volume 62, Issue 2, 15 July 2007, Pages 158-167
Amygdala
and Orbitofrontal Reactivity to Social Threat in
Individuals with Impulsive Aggression
Emil F. Coccaro, Michael S. McCloskey, Daniel A. Fitzgerald and K.
Luan Phan
Biological
Psychiatry. Volume 62, Issue 2, 15 July 2007, Pages 168-178
Advances in
Functional Magnetic Resonance Imaging: Technology and Clinical Applications
Bradford C.
Dickerson
Neurotherapeutics. Volume 4, Issue 3, July
2007, Pages 360-370
Involvement of
nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor
Ashish Dhir and S.K. Kulkarni
European
Journal of Pharmacology. Volume 568, Issues 1-3, 30 July 2007, Pages 177-185
Are
Anti-Nuclear Antibodies Common in Affective Disorders? A Review of the Past 35
Years
Brian Appleby
Psychosomatics 48:286-289, August 2007
Orbitofrontal Cortex and Its Contribution to
Decision-Making
Jonathan D. Wallis
Annual
Review of Neuroscience. Vol. 30: 31-56
Anatomical and Physiological Plasticity of Dendritic Spines
Veronica A. Alvarez
and Bernardo L. Sabatini
Annual
Review of Neuroscience. Vol. 30: 79-97
The Medial Temporal Lobe and Recognition
Memory
H. Eichenbaum,
A.P. Yonelinas, and C. Ranganath
Annual
Review of Neuroscience. Vol. 30: 123-152
Multiple Dopamine Functions at Different
Time Courses
Wolfram Schultz
Annual
Review of Neuroscience. Vol. 30: 259-288
[I-123] ADAM and SPECT in patients with
borderline personality disorder and healthy control subjects
Walter Koch, Nadine Schaaff,
Gabriele Pöpperl, Christoph Mulert, Georg Juckel,
Markus Reicherzer, Christoff Ehmer-von Geiso, Hans-Jürgen Möller, Ulrich Hegerl, Klaus Tatsch,
Oliver Pogarell
J Psychiatry Neurosci 2007;32(4):234-40
TEXTO
GRATUITO
New genes associated with schizophrenia in neurite formation: a review of cell culture experiments
A Bellon
Molecular Psychiatry (2007) 12,
620–629
Patterns of gene expression in the limbic system
of suicides with and without major depression
A Sequeira, T Klempan,
L Canetti, J ffrench-Mullen, C Benkelfat, G A Rouleau and G Turecki
Molecular Psychiatry (2007) 12,
640–655
Novel Therapeutics
for Schizophrenia: Targeting Glycine Modulation of
NMDA Glutamate Receptors
Stephen M. Stahl
CNS Spectr.
2007;12(6):423-427
TEXTO
GRATUITO
Depression
and stress: is there an endophenotype?
Andrea Feijo
Mello, Mario Francisco Juruena, Carmine M Pariante, Audrey R Tyrka, Lawrence H Price, Linda L
Carpenter, Jose Alberto Del
Porto
Rev Bras Psiquiatr. 2007;29(Supl I):S13-8
TEXTO
GRATUITO
Brain-immune
interactions and implications in psychiatric disorders
Andrea H Marques, Giovanni Cizza, Esther Sternberg